1,000,000 Shares LeMaitre Vascular, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • July 16th, 2021 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • October 3rd, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
LeMaitre Vascular, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of shares (the “Firm Shares”) and, at the election of the Underwriters, up to additional shares (the “Optional Shares”) of Common Stock, par value $0.01 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
LEMAITRE VASCULAR, INC. and _____________, As Warrant Agent Form of Debt Securities Warrant Agreement Dated As Of __________Debt Securities Warrant Agreement • May 20th, 2020 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
This Debt Securities Warrant Agreement (this “Agreement”), dated as of [●], between Lemaitre Vascular, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
NON-QUALIFIED STOCK OPTION AGREEMENT FOR COMPANY EMPLOYEES UNDER LEMAITRE VASCULAR, INC.Non-Qualified Stock Option Agreement • March 9th, 2018 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
Pursuant to the LeMaitre Vascular, Inc. 2006 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), LeMaitre Vascular, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan. This Stock Option is not intended to be an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended.
PLEDGE AND SECURITY AGREEMENT dated as of June 22, 2020 Among LEMAITRE VASCULAR, INC., as a Grantor, and KEYBANK NATIONAL ASSOCIATION, as the Administrative Agent, for the benefit of THE SECURED CREDITORSPledge and Security Agreement • June 24th, 2020 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
THIS PLEDGE AND SECURITY AGREEMENT, dated as of June 22, 2020 (as the same may be amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), is among LeMaitre Vascular, Inc., a Delaware corporation (the “Borrower”; together with each Additional Grantor (as defined below) that becomes a party hereto pursuant to Section 9.14, collectively, the “Grantors” and, individually, each a “Grantor”), and KeyBank National Association, as administrative agent (the “Administrative Agent”), for the benefit of the Secured Creditors (as defined below):
FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • May 26th, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Delaware
This Agreement made and entered into this ____ day of ______, (the “Agreement”), by and between LeMaitre Vascular, Inc., a Delaware corporation (the “Company,” which term shall include, where appropriate, any Entity (as hereinafter defined) controlled, directly or indirectly, by the Company) and ____________ (the “Indemnitee”):
LEMAITRE VASCULAR, INC. 1,430,000 Shares Common Stock ($0.01 par value) Underwriting AgreementUnderwriting Agreement • May 30th, 2014 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
LeMaitre Vascular, Inc., a Delaware corporation (the “Company”), confirms its agreement pursuant to this Underwriting Agreement (this “Agreement”) to the several underwriters listed on Schedule A attached hereto (collectively, the “Underwriters”), for whom Canaccord Genuity Inc. and Stifel, Nicolaus & Company, Incorporated are acting as representatives (in such capacity, the “Representatives”), with respect to the issue and sale by the Company of an aggregate total of 1,430,000 shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value (the “Common Stock”), the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of Firm Shares set forth in Schedule A hereto, and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of the option described in Section 1 hereof to purchase all or any part of 214,500 additional shares of Common Stock to cover over-allotments, if any. The Firm Shares and all or an
PATENT SUBLICENSE AGREEMENT,Patent Sublicense Agreement • June 22nd, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Arizona
This Agreement, by and between IMPRA, Inc., an Arizona corporation (hereinafter called LICENSOR), and Endomed, Inc., also an Arizona corporation (hereinafter called LICENSEE), effective as of Match 7, 2003,
NORTHWEST PARK LEASE BY AND BETWEEN (AS LANDLORD) AND LEMAITRE VASCULAR, INC. (AS TENANT) FOR PREMISES AT BURLINGTON, MASSACHUSETTSLemaitre Vascular Inc • December 23rd, 2013 • Surgical & medical instruments & apparatus • Massachusetts
Each reference in this Lease to any of the following subjects shall be construed to incorporate the data stated for that subject in this Section 1.1.
INCENTIVE STOCK OPTION AGREEMENT UNDER LEMAITRE VASCULAR, INC.Incentive Stock Option Agreement • March 9th, 2018 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
Pursuant to the LeMaitre Vascular, Inc. 2006 Stock Option and Incentive Plan as amended through the date hereof (the “Plan”), LeMaitre Vascular, Inc. (the “Company”) hereby grants to the Optionee named above an option (the “Stock Option”) to purchase on or prior to the Expiration Date specified above all or part of the number of shares of Common Stock, par value $0.01 per share (the “Stock”), of the Company specified above at the Option Exercise Price per Share specified above subject to the terms and conditions set forth herein and in the Plan.
northwest park OFFICE lease by and between nwp retail 18 llc (AS LANDLORD) and LEMAITRE VASCULAR, INC. (AS TENANT) FOR PREMISES AT 32-34 THIRD AVENUE burlington, massachusettsOffice Lease • December 3rd, 2019 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
LICENSE AGREEMENTLicense Agreement • June 22nd, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Delaware
This AGREEMENT (hereinafter “Agreement”) effective as of February 11, 1992 (“Effective Date”), by and between United States Surgical Corporation, a corporation organized and existing under the laws of the State of Delaware, having executive offices at 150 Glover Avenue, Norwalk, Connecticut 06856 (hereinafter “USSC”) and SPINNAKER R&D ASSOCIATES, a general partnership organized and existing under the laws of the State of New Mexico, having offices at 5300 DTC Parkway, Suite 270, Englewood, Colorado, 80111, on behalf of itself, the University of New Mexico, and the Inventors, Wolff M. Kirsch, M.D., Yong Hua Zhu, M.D., and Robert B. Cushman, (hereinafter “INVENTORS”), together owners of all of the PATENTS RIGHTS and other rights herein transferred, (altogether hereinafter referred to as “LICENSOR”).
SUPPLY AND DISTRIBUTION AGREEMENTSupply and Distribution Agreement • March 31st, 2008 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
This agreement is made as of January 1, 2005 (the “Effective Date”) by and between Biomateriali Srl, an Italian limited liability company having its registered offices at Cittadella della Ricerca s.s.7 per Mesagne, 72100 Brindisi, Italy (“BIOMATERIALI”) and Edwards Lifesciences AG, a corporation organised under the laws of Switzerland and having its business office at Chemin du Glapin 6, 1162 Saint-Prex, Switzerland (“EDWARDS”).
CREDIT AGREEMENT dated as of June 22, 2020 among LEMAITRE VASCULAR, INC., as Borrower, THE LENDING INSTITUTIONS NAMED HEREIN, as Lenders, and KEYBANK NATIONAL ASSOCIATION, as an LC Issuer, Swing Line Lender and as the Administrative Agent,Credit Agreement • June 24th, 2020 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
This CREDIT AGREEMENT is entered into as of June 22, 2020 among LeMaitre Vascular Inc., a Delaware corporation, as the borrower (the “Borrower”), the lenders from time to time party hereto (each a “Lender” and collectively, the “Lenders”), and KeyBank National Association, as the administrative agent (in such capacity, the “Administrative Agent”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 22nd, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
THIS EMPLOYMENT AGREEMENT (this “Agreement”) is made by and between LeMaitre Vascular, Inc., a Delaware corporation with an address at 63 Second Avenue, Burlington, Massachusetts (the “Company”) and Joseph P. Pellegrino, an individual with a residence at 68 Beacon Street, Boston, Massachusetts (the “Executive”) as of April 20th, 2006.
Lemaitre Vascular, Inc. and _____________, As Warrant Agent Form of Preferred Stock Warrant Agreement Dated As Of __________Lemaitre • May 20th, 2020 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • New York
This Preferred Stock Warrant Agreement (this “Agreement”), dated as of [●], between Lemaitre Vascular, Inc., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
Neovasc Letterhead]Option Agreement • August 7th, 2014 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
We refer to the Purchase Option Agreement, dated for reference as of December 30, 2008 and with an effective date of January 26, 2009, by and between LeMaitre Vascular, Inc., a Delaware corporation, on the one hand, and Neovasc Inc., a Federal Canadian Corporation and Neovasc Medical Inc., a British Columbia corporation, on the other hand, as amended by instruments dated January 22, 2009, January 5, 2012 and October 1, 2012 (as amended, the “Option Agreement”). Except as otherwise indicated herein, capitalized terms shall have the meaning ascribed to them in the Option Agreement.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • November 7th, 2013 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
ASSET PURCHASE AGREEMENT (this “Agreement”), dated August 28, 2013, by and among LeMaitre Vascular, Inc., a Delaware corporation with an address at 63 Second Ave., Burlington, Massachusetts 01803 (the “Purchaser”) and InaVein, LLC, a Delaware limited liability company, with an address at 420 Bedford Street, Suite 130, Lexington, MA 02420 (the “Seller”).
As of September 25, 2006 LeMaitre Vascular, Inc.Lemaitre Vascular Inc • October 3rd, 2006 • Surgical & medical instruments & apparatus
EXECUTIVE RETENTION AND SEVERANCE AGREEMENTExecutive Retention and Severance Agreement • June 22nd, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
THIS EXECUTIVE RETENTION AND SEVERANCE AGREEMENT is made and entered into as of June 20, 2006 (the “Effective Date”), by and between Lemaitre Vascular, Inc., a Delaware corporation (the “Company”), and David B. Roberts (the “Executive”).
THIRD AMENDED AND RESTATED REVOLVING LOAN AND SECURITY AGREEMENTRevolving Loan and Security Agreement • May 26th, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
This Third Amended and Restated Revolving Loan and Security Agreement (the “Agreement”) is made as of May 20, 2006 between LEMAITRE VASCULAR, INC. formerly known as Vascutech, Inc., having its principal place of business at 63 Second Avenue, Burlington, Massachusetts 01803 (the “Borrower”) and BROWN BROTHERS HARRIMAN & CO., having a place of business at 40 Water Street, Boston, Massachusetts 02109 (the “Bank”).
RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE LEMAITRE VASCULAR, INC.Restricted Stock Unit Award Agreement • March 9th, 2018 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
LeMaitre Vascular, Inc. (the “Company”) has selected you to receive an award of the Restricted Stock Units identified above, subject to the terms set forth on Appendix A hereto, the provisions of the LeMaitre Vascular, Inc. 2006 Stock Option and Incentive Plan, as amended (the “Plan”), and the attached Statement of Terms and Conditions.
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • May 26th, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
ASSET PURCHASE AGREEMENT, dated February 2, 2005 (the “Closing Date”), by and among LeMaitre Acquisition, LLC, a Delaware limited liability company with a mailing address at 63 Second Ave., Burlington, Massachusetts 01803 (the “Purchaser”) and Endomed, Inc., an Arizona corporation with a mailing address at 10220 South 51st Street, Suite 1, Phoenix, AZ 85044 (the “Seller”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • June 24th, 2020 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Delaware
Asset Purchase Agreement (this “Agreement”), dated June 22, 2020 by and between Lemaitre Vascular, Inc., a Delaware corporation with an address at 63 Second Ave., Burlington, Massachusetts 01803 (the “Purchaser”) and Artegraft, Inc., a Delaware corporation, with an address at 206 North Center Drive, North Brunswick, NJ 08902 (the “Seller”).
FIFTH AMENDMENT OF LEASEOf Lease • March 29th, 2010 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS AMENDMENT made and entered into this 23rd day of March, 2010 (the “Effective Date”) by and between Rodger P. Nordblom and Peter C. Nordblom, as Trustees of Northwest Associates (“Landlord”) and LeMaitre Vascular, Inc. (“Tenant”).
THIRD AMENDED AND RESTATED TERM LOAN AGREEMENTTerm Loan Agreement • June 22nd, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
This Third Amended and Restated Term Loan Agreement (the “Agreement”) is made as of May 20, 2006 between LEMAITRE VASCULAR, INC. formerly known as Vascutech, Inc., a Delaware corporation, having its principal place of business at 26 Ray Avenue, Burlington, Massachusetts 01803 (the “Borrower”) and BROWN BROTHERS HARRIMAN & CO., having a place of business at 40 Water Street, Boston, Massachusetts 02109 (the “Bank”).
SIXTH AMENDMENT OF LEASEOf Lease • December 23rd, 2013 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS SIXTH AMENDMENT is made and entered into this 20th day of December, 2013 (the “Effective Date”), by and between the NWP Building 5 LLC (“Landlord”) and LeMaitre Vascular, Inc. (“Tenant”).
ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 12th, 2020 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Delaware
ASSET PURCHASE AGREEMENT (this “Agreement”), dated October 11, 2019, by and among LeMaitre Vascular, Inc., a Delaware corporation with an address at 63 Second Ave., Burlington, Massachusetts 01803 (the “Purchaser”), Admedus Ltd, an Australian limited liability company with an address at Toowong Tower, Level 3, 9 Sherwood Rd, Toowong QLD 4066 Australia (the “Parent”), Admedus Regen Pty Ltd, a proprietary limited company with a registered address at Toowong Tower, Level 3, 9 Sherwood Rd, Toowong QLD 4066 Australia (“ARPL”), Admedus Biomanufacturing Pty Ltd, a proprietary limited company with a registered address at Toowong Tower, Level 3, 9 Sherwood Rd, Toowong QLD 4066 Australia (“ABPL”), Admedus Investments Pty Limited, a proprietary limited company with a registered address at Toowong Tower, Level 3, 9 Sherwood Rd, Toowong QLD 4066 Australia (“AIPL”), Admedus (NZ) Ltd, a limited liability company with a registered address at Level 1, 50 Customhouse Quay, Wellington, 6011, New Zealand
FORM OF RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE LEMAITRE VASCULAR, INC. AMENDED AND RESTATEDRestricted Stock Unit Award Agreement • February 28th, 2022 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
LeMaitre Vascular, Inc. (the “Company”) has selected you to be eligible to receive the target number of Restricted Stock Units identified above, subject to achievement of the Performance Goals during the Performance Period set forth on Appendix A hereto, the provisions of the LeMaitre Vascular, Inc. Amended and Restated 2006 Stock Option and Incentive Plan, as amended (the “Plan”), and the attached Statement of Terms and Conditions.
EXECUTIVE RETENTION AND SEVERANCE AGREEMENTExecutive Retention and Severance Agreement • May 26th, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
THIS EXECUTIVE RETENTION AND SEVERANCE AGREEMENT is made and entered into as of October 10, 2005 (the “Effective Date”), by and between LeMaitre Vascular, Inc. (the “Company”) and George W. LeMaitre (the “Executive”).
MANAGING DIRECTOR EMPLOYMENT AGREEMENTManaging Director Employment Agreement • March 31st, 2009 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS MANAGING DIRECTOR EMPLOYMENT AGREEMENT (this “Agreement”) is made by and between LeMaitre Vascular GmbH., a German limited liability company with an address at Otto-Volger-Str 5 a/b, 65843 Sulzbach, Germany (the “Company”) and Peter R. Gebauer, an individual with a residence at Taubenweg 16, 61462 Koenigstein, Germany (the “Executive”) as of October 1, 2008.
EXECUTIVE SERVICE AGREEMENTExecutive Service Agreement Agreement • May 26th, 2006 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus • Massachusetts
AGREEMENT (this “Agreement”) made this 17th day of September, 2003, by and between LEMAITRE VASCULAR, INC., f/k/a Vascutech, Inc., a Delaware corporation with a principal place of business at 63 Second Avenue, Burlington, Massachusetts 01803 (“LeMaitre”), successor-in-interest to Vascutech, Inc., a Massachusetts corporation, and PETER GEBAUER an individual residing at Am Waldfeld 17, Bad Soden, Germany (“Executive”).
SIXTH AMENDMENT OF LEASESixth Amendment of Lease • November 7th, 2023 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS SIXTH AMENDMENT OF LEASE (this “Amendment”) is made and entered into as of this 18th day of September, 2023 (the “Effective Date”) by and between NWP BUILDING 4 LLC, a Massachusetts limited liability company (“Landlord”) and LEMAITRE VASCULAR, INC., a Massachusetts corporation (“Tenant”).
Seventh amendment of leaseSeventh Amendment of Lease • November 1st, 2019 • Lemaitre Vascular Inc • Surgical & medical instruments & apparatus
THIS SEVENTH AMENDMENT OF LEASE (this “Amendment”) is made and entered into as of this 29th day of October, 2019 (the “Effective Date”) by and between NWP BUILDING 5 LLC, a Massachusetts limited liability company (“Landlord”) and LEMAITRE VASCULAR, INC., a Delaware corporation (“Tenant”).
SHARE PURCHASE DEEDLemaitre Vascular Inc • November 6th, 2014 • Surgical & medical instruments & apparatus • Victoria
